NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

I would like to think that the approval of Sawston would be a strong indicator that the final steps are in play and there’s a strong probability that the UK likes what they see.

The market is telling you that this isn't the case. The market is telling you the value of NWBO's manufacturing operation at Sawston, without commercial production of DCVax-L. Because the manufacturing piece is all they've got.

They have a failed trial and they know they cannot get approval for DCVax-L no matter how many endpoints they change and no matter what historical data they use for comparison. They've actually known this for at least six years. It's about time everyone here woke up to this simple reality.

Companies with successful, efficacious trial data do not sit on that data for 15+ months. Sorry, but that's a fact no matter what excuses you want to invent.